We advise hospitals, pharmaceutical firms, and biotech investors on licensing, investment, and data-governance matters under Vision 2030’s Health Transformation Program.
Our support includes SFDA and Ministry of Health licensing for hospitals, laboratories, and distribution networks, along with PPP frameworks for healthcare operations and privatization initiatives.
We also handle clinical data governance, PDPL-compliant privacy frameworks, and research-ethics alignment. In addition, we guide clients on healthcare M&A, cross-border partnerships, and investment structuring with leading regional health networks.
